Neutrophil, Lymphocyte and Platelet as a Predictor for AKI and Mortality
Risk Factor of Acute Kidney Injury After Open Heart Surgery With Cardiopulmonary Bypass
1 other identifier
observational
1,099
1 country
1
Brief Summary
Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 25, 2016
CompletedFirst Posted
Study publicly available on registry
September 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedNovember 15, 2016
September 1, 2016
7 months
September 25, 2016
November 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acute kidney injury
acute kidney injury during postoperative seven days defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria
postoperative day seven
Secondary Outcomes (1)
All-cause mortality
postoperative seven years
Other Outcomes (3)
Postoperative length of hospital stay
postoperative two month
Postoperative length of ICU stay
postoperative two months
Postoperative incidence of complications
postoperative two months
Study Arms (1)
Cardiovascular surgery with cardiopulmonary bypass
Cardiovascular surgery with cardiopulmonary bypass
Interventions
Patients who underwent cardiovascular surgery including valve replacement or thoracic aortic surgery with cardiopulmonary bypass
Eligibility Criteria
adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass (CPB), including valve replacement and surgery on the thoracic aorta at the Seoul National University Hospital between 2007 and 2015
You may qualify if:
- Adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass (CPB), including valve replacement and surgery on the thoracic aorta at the Seoul National University Hospital between 2007 and 2015
You may not qualify if:
- Missing preoperative serum creatinine (sCr) values
- Missing preoperative platelet, neutrophil and lymphocyte counts
- Patients who underwent preoperative hemodialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
September 25, 2016
First Posted
September 27, 2016
Study Start
April 1, 2016
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
November 15, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share